Although RNAseq analysis of the lung tissues from these mice demonstrated no significant difference in the metastatic tumor burden between control and rTIMP2-treated mice, the expression of Klf4, a premetastatic niche marker (36), was significantly reduced in both cohorts of rTIMP2 mice. This evidence concerns the gene KLF4 and neoplasm.